Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Thyroid Neoplasms 8Carcinoma, Medullary 6Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 3Thyroid Cancer, Papillary 2Familial medullary thyroid carcinoma 2Adenocarcinoma, Follicular 2Thyroid cancer, medullary 1Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Thyroid Gland Carcinoma 1Esthesioneuroblastoma, Olfactory 1Differentiated Thyroid Cancer 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cetuximab 3Biopsy 3Radiotherapy, Intensity-Modulated 2Immunohistochemistry 2Gene Expression Profiling 2Cisplatin 2vandetanib 1sintilimab 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Nivolumab 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Celecoxib 1Aspirin 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × vandetanib × Head & Neck × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡